Friday, March 29, 2024
Home Tags CSL – Seqirus

Tag: CSL – Seqirus

CSL’s $800 million vaccine manufacturing facility in Melbourne nears completion

CSL Seqirus has reached a major milestone in the construction of its new cutting-edge manufacturing facility for vaccine and antivenom manufacturing. 

TGA approves domestic manufacture of AstraZeneca vaccine

CSL has been given the nod by the Therapeutic Goods Administration (TGA) to commence the manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia. TGA’s...
Advertisement

Bits Orchestra

Manufacturing Catalyst

Featured Article

Top 3 digitisation outcomes for Aussie manufacturers

As the Australian manufacturing sector faces the challenges and transformations that come with rapid globalisation, the role of digital technology within the industry has never been more critical.Â